source Post navigation Tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight – Investors | Eli Lilly and Company Diabetes: What are some new research projects in the field of ‘smart’ insulin? | Explained – The Hindu
